A Comparison of Liposomal Formulations of Doxorubicin with Drug Administered in Free Form
- 1 January 2001
- journal article
- research article
- Published by Springer Nature in Drug Safety
- Vol. 24 (12) , 903-920
- https://doi.org/10.2165/00002018-200124120-00004
Abstract
The anthracycline antibiotic doxorubicin has wide activity against a number of human neoplasms and is used extensively both as a single agent and in combination regimens. In addition to the use of...Keywords
This publication has 54 references indexed in Scilit:
- Phase II Study of Liposomal Doxorubicin in Advanced Gynecologic CancersGynecologic Oncology, 2000
- Development of liposomal anthracyclines: from basics to clinical applications1This paper is based on a lecture presented at the 8th International Symposium on recent Advances in Drug Delivery Systems (Salt Lake City, UT, USA, 1997).1Journal of Controlled Release, 1998
- DexrazoxaneDrugs, 1998
- Polyethylenglykol-umhülltes (pegyliertes) liposomales DoxorubicinDrugs, 1997
- Anthrazykline in der KrebstherapieDrugs, 1997
- Liposomal doxorubicin‐induced toxicity: Depletion and impairment of phagocytic activity of liver macrophagesInternational Journal of Cancer, 1995
- Pharmacology of adriamycin: The message to the clinicianEuropean Journal of Cancer and Clinical Oncology, 1988
- Cholesterol content of small unilamellar liposomes controls phospholipid loss to high density lipoproteins in the presence of serumFEBS Letters, 1980
- Cancer of the BreastNew England Journal of Medicine, 1980
- Invitro and invivo studies with adriamycin liposomesBiochemical and Biophysical Research Communications, 1979